Gene therapy: New and future treatments for uveitis DOI Creative Commons
Hui Yang, Meng Tian, Shengping Hou

и другие.

Eye & ENT Research, Год журнала: 2024, Номер unknown

Опубликована: Дек. 12, 2024

Abstract Uveitis, characterized by intraocular inflammation, has significant management challenges due to its diverse etiologies and complicated pathophysiology. The current first‐line treatments primarily aim calm inflammation with the underlying causes unaffected, often associated systemic side effects, limited long‐term efficacy, disease recurrence. Gene therapies, as powerful therapeutic approaches, have been applied treat various genetic non‐genetic diseases. However, development of gene therapy for uveitis investigated less. This review discusses possible targets approaches analyzing some research examples in exogenous expression, RNAi, antisense therapy, CRISPR editing system. Furthermore, we discuss limitations listed therapies propose future directions potential strategies overcome challenges.

Язык: Английский

Single‐cell RNA sequencing reveals inflammatory retinal microglia in experimental autoimmune uveitis DOI Creative Commons
Jiangyi Liu,

Xingyun Liao,

Na Li

и другие.

MedComm, Год журнала: 2024, Номер 5(4)

Опубликована: Апрель 1, 2024

Abstract Autoimmune uveitis (AU) is a kind of immune‐mediated disease resulting in irreversible ocular damage and even permanent vision loss. However, the precise mechanism underlying dynamic immune changes contributing to initiation progression AU remains unclear. Here, we induced an experimental (EAU) model with IRBP 651‐670 found that day[D]14 was inflammatory summit remarking clinical histopathological manifestations activation retinal microglia exhibited time‐dependent pattern EAU course. We conducted single‐cell RNA sequencing cells mice at four time points constituting largest proportion, especially on D14. A novel subtype ( Cd74 high Ccl5 ) identified peak closely associated modulating responses. In vitro experiments indicated stimuli proinflammatory upregulation CD74 CCL5, overexpression elicited their phenotype via nuclear factor‐kappa B signaling could be attenuated by treatment neutralizing CCL5 antibody certain extent. In‐vivo blockade effectively alleviated microglial EAU. Therefore, propose targeting as promising strategies for treatment.

Язык: Английский

Процитировано

7

Ocular immune‐related diseases: molecular mechanisms and therapy DOI
Yakun Wang, Shangze Gao,

Fan Cao

и другие.

MedComm, Год журнала: 2024, Номер 5(12)

Опубликована: Ноя. 28, 2024

Abstract Ocular immune‐related diseases, represent a spectrum of conditions driven by immune system dysregulation, include but not limit to uveitis, diabetic retinopathy, age‐related macular degeneration, Graves’ ophthalmopathy, etc. The molecular and cellular mechanisms underlying these diseases are typically dysfunctioned responses targeting ocular tissues, resulting in inflammation tissue damage. Recent advances have further elucidated the pivotal role different development, progression, as well management various diseases. However, there is currently relative lack connection between treatments several In this review, we discuss recent findings related immunopathogenesis above‐mentioned particular, summarize types cells, inflammatory mediators, associated signaling pathways that involved pathophysiology ophthalmopathies. Furthermore, also future directions utilizing anti‐inflammatory regime This will facilitate better understanding pathogenesis provide new insights for treatment approaches.

Язык: Английский

Процитировано

6

Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics DOI
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta

и другие.

Journal of Neuroimmunology, Год журнала: 2024, Номер 395, С. 578433 - 578433

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

3

Comparative models of uveitis DOI Creative Commons

Olivia S. Knutson,

So‐Young Choi,

Sally L Williams

и другие.

Eye, Год журнала: 2025, Номер unknown

Опубликована: Фев. 18, 2025

Abstract Several clinical subtypes of uveitis exist yet specific immunopathogenic mechanisms involved remain unclear. Ex vivo studies are limited by lack fresh retinal biopsies and have relied on aqueous humour or peripheral blood, which may not directly reflect disease. The aim this review is to compare the various in models their contributions our understanding disease processes. These models, although unable all signs, provided insight into contribution genes molecules, characterisation effector T-cells, cell trafficking tissues, tissue-resident myeloid cells mechanism(s) action several anti-inflammatory compounds. In an excellent resource with study molecular cellular processes involved. Recent refinements improved imaging, application omics greatly increased number readouts translational opportunities. Future approaches vitro will also be discussed.

Язык: Английский

Процитировано

0

Transcriptomic analysis unveils bona fide molecular signatures of microglia under conditions of homeostasis and viral encephalitis DOI Creative Commons
Felix Mulenge, Olivia Luise Gern,

Lena Mareike Busker

и другие.

Journal of Neuroinflammation, Год журнала: 2024, Номер 21(1)

Опубликована: Авг. 17, 2024

Microglia serve as a front-line defense against neuroinvasive viral infection, however, determination of their actual transcriptional profiles under conditions health and disease is challenging. Here, we used various experimental approaches to delineate the landscape microglia during infection. Intriguingly, multiple activation genes were found be artificially induced in sorted demonstrated that shear stress encountered cell sorting was one key inducers. Post-hoc analysis revealed publicly available large-scale single-cell RNA sequencing datasets significantly tainted by aberrant signatures are associated with sorting. By exploiting ribosomal tagging approach, developed strategy enrich microglia-specific transcripts comparing immunoprecipitated total RNA. Such enriched instrumental defining bona fide virus These unified microglial may benchmark retrospectively assess ex vivo artefacts from atlases. Leveraging translatome, enrichment implicated T-cell cytokine production course VSV data linked re-stimulation further underscored involved shaping antiviral responses brain. Collectively, our study defines steady state encephalitis highlights cellular interactions between T cells contribute control dissemination.

Язык: Английский

Процитировано

1

Multi-omics in exploring the pathophysiology of diabetic retinopathy DOI Creative Commons
Xinlu Li, Xifeng Dong, Wen Zhang

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Дек. 11, 2024

Diabetic retinopathy (DR) is a leading global cause of vision impairment, with its prevalence increasing alongside the rising rates diabetes mellitus (DM). Despite retina's complex structure, underlying pathology DR remains incompletely understood. Single-cell RNA sequencing (scRNA-seq) and recent advancements in multi-omics analyses have revolutionized molecular profiling, enabling high-throughput analysis comprehensive characterization biological systems. This review highlights significant contributions scRNA-seq, conjunction other technologies, to research. Integrated scRNA-seq transcriptomic revealed novel insights into pathogenesis, including alternative transcription start site events, fluctuations cell populations, altered gene expression profiles, critical signaling pathways within retinal cells. Furthermore, by integrating genetic association studies analyses, researchers identified biomarkers, susceptibility genes, potential therapeutic targets for DR, emphasizing importance specific types disease progression. The integration metabolomics has also been instrumental identifying metabolites dysregulated associated DR. It highly conceivable that continued synergy between approaches will accelerate discovery mechanisms development interventions

Язык: Английский

Процитировано

0

Gene therapy: New and future treatments for uveitis DOI Creative Commons
Hui Yang, Meng Tian, Shengping Hou

и другие.

Eye & ENT Research, Год журнала: 2024, Номер unknown

Опубликована: Дек. 12, 2024

Abstract Uveitis, characterized by intraocular inflammation, has significant management challenges due to its diverse etiologies and complicated pathophysiology. The current first‐line treatments primarily aim calm inflammation with the underlying causes unaffected, often associated systemic side effects, limited long‐term efficacy, disease recurrence. Gene therapies, as powerful therapeutic approaches, have been applied treat various genetic non‐genetic diseases. However, development of gene therapy for uveitis investigated less. This review discusses possible targets approaches analyzing some research examples in exogenous expression, RNAi, antisense therapy, CRISPR editing system. Furthermore, we discuss limitations listed therapies propose future directions potential strategies overcome challenges.

Язык: Английский

Процитировано

0